This inventor holds 1 USPTO granted patent. Top assignee: Oravax-Merieux Co.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Thomas Ermak: Innovator in Vaccine Development
Introduction
Thomas Ermak is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of vaccine development, particularly in the fight against Helicobacter pylori infections. His innovative work has led to the creation of a unique vaccine that holds promise for prophylactic and antibacterial therapy.
Latest Patents
Thomas Ermak holds a patent for a multimeric, recombinant urease vaccine. This patent describes methods and compositions designed for the prevention and treatment of Helicobacter infections in humans. The immunogenic composition consists of multiple multimeric complexes, each made up of recombinant, enzymatically inactive Helicobacter pylori urease. Specifically, each complex is composed of six Urease A subunits and six Urease B subunits. Alternatively, the composition may include a mixture of multimeric complexes, with variations in the number of Urease A and B subunits.
Career Highlights
Throughout his career, Thomas has demonstrated a commitment to advancing medical science through innovative solutions. His work at Oravax-Merieux Co. has positioned him as a key player in the development of vaccines aimed at combating bacterial infections. His dedication to research and development has resulted in impactful contributions to public health.
Collaborations
Thomas has collaborated with notable colleagues, including William D Thomas and Hitesh Bhagat. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
In summary, Thomas Ermak is a distinguished inventor whose work in vaccine development has the potential to significantly impact the treatment of Helicobacter pylori infections. His innovative approaches and collaborations highlight his dedication to advancing medical science.